What is the current market size and projected growth of the global generative AI in healthcare market?

The global generative AI in healthcare market was valued at USD 2.70 billion in 2025 and is projected to reach USD 32.72 billion by 2033, exhibiting a CAGR of 37.21% over the forecast period.

Which factors are driving the adoption of generative AI in the healthcare industry?

Increasing implementation of AI-based solutions for drug discovery, clinical documentation, diagnostics & patient engagement is driving market growth. Other factors such as growing healthcare data, technological advancements in AI, and the need to enhance clinical efficiency and patient outcomes are expected to further support this growth.

What are the major challenges hindering the growth of generative AI in healthcare?

Key challenges include potential biases and inaccuracies in AI systems, privacy concerns, regulatory hurdles, and the need for continuous monitoring and validation to ensure that AI systems remain reliable and fair.

Who are the key players operating in the generative AI in healthcare market?

The key players are Microsoft, Google LLC, NVIDIA Corporation, Amazon Web Services, IBM, Oracle, Abridge AI, Insilico Medicine, Johnson & Johnson, SAXON INFOSYSTEMS, Tempus AI, OpenAI, Hippocratic AI, John Snow Labs, and Aidoc.

Which technological trends are influencing the generative AI in healthcare industry?

Emerging trends include the proliferation of multimodal diagnostics, integration of AI into clinical and administrative workflows, deployment of AI microservices in the cloud, and the development of LLMs with potential healthcare applications.

Which regions are leading in the adoption of generative AI in healthcare, and why?

North America leads with a 40.48% market share in 2025 (valued at USD 1.09 billion), driven by robust healthcare infrastructure, early technology adoption, and strong investments. Asia Pacific is the fastest-growing region, projected to grow at a CAGR of 39%, supported by rapid digital transformation, government support, and large-scale data generation.

What are the most in-demand components and functional segments in the generative AI in healthcare market?

The solution segment generated USD 1.84 billion in revenue in 2025, and the administrative process optimization segment accounted for a share of 56.95%, owing to the automation of clinical documentation, billing, scheduling & claims management.

How do regulatory frameworks impact the deployment of generative AI solutions in healthcare?

In the U.S., HIPAA regulates privacy and security for patient data, while the EU Medical Device Regulation (MDR) governs safety, transparency, and post-market surveillance for AI-based medical devices, ensuring compliance and patient safety.

How can this report help me explain the benefits of adopting generative AI solutions in my healthcare organization?

This report shows how you can use generative AI to improve efficiency, automate documentation, improve the accuracy of diagnoses, streamline workflows, and enable personalized patient care. This will help you talk to stakeholders about the real value.

How does this report help me understand the competitive landscape and identify potential technology partners in generative AI for healthcare?

The report presents profiles of the key technology companies, their products and services, recent partnerships, and innovation areas, providing a clear overview of the competitive landscape and helping identify potential partnerships or strategies to be benchmarked.

How does this report help me assess market growth and evaluate investment opportunities in generative AI for healthcare?

Detailed market sizing, growth forecasts, segmentation, and regional analysis enable you to gauge demand, discover high growth areas like clinical research, and identify investment opportunities.

Size | Kings Research

Market Definition

The generative AI in healthcare market encompasses the portion of the healthcare industry dedicated to developing, adopting, and utilizing artificial intelligence systems capable of autonomously generating new content, data, or solutions. The market comprises technologies that generate medical images, clinical notes, synthetic patient data, support drug design, and enable diagnostics and personalized treatment planning. These AI tools leverage sophisticated machine learning algorithms, including deep learning and large language models, to boost research and development, optimize clinical processes, improve patient care, and streamline operations across hospitals and healthcare organizations.

Generative AI in Healthcare Market Overview

The global generative AI in healthcare market size was valued at USD 2.70 billion in 2025 and is projected to grow from USD 3.57 billion in 2026 to USD 32.72 billion by 2033, exhibiting a CAGR of 37.21% during the forecast period. This rapid growth is driven by the increasing adoption of AI-powered solutions in areas such as drug discovery, clinical documentation, diagnostics, and patient engagement.

Major companies operating in the global generative AI in healthcare market are Microsoft, Google LLC, NVIDIA Corporation, Amazon Web Services, Inc., IBM, Oracle, Abridge AI, Inc., Insilico Medicine, Johnson & Johnson, SAXON INFOSYSTEMS, Tempus AI, Inc., OpenAI, Hippocratic AI, John Snow Labs, Inc., and Aidoc.

The growth of healthcare data, the development of AI technologies, and the increasing demand for enhanced clinical efficiency and improved patient outcomes are further driving market expansion. With the ongoing digital transformation in healthcare, generative AI is poised to reshape the healthcare landscape globally.

In March 2024, Google Cloud announced new generative AI advancements for healthcare and life sciences, including enhanced Vertex AI Search, the Healthcare Data Engine, and MedLM tools. These solutions aim to streamline data access, improve clinical workflows, and support interoperability, helping healthcare organizations deliver more efficient and effective patient care.

Key Market Highlights

The global generative AI in healthcare market size was USD 2.70 billion in 2025.
The market is projected to grow at a CAGR of 37.21% from 2026 to 2033.
North America held a share of 40.48% in 2025, valued at USD 1.09 billion.
The solution segment garnered USD 1.84 billion in revenue in 2025.
The administrative process optimization segment is expected to reach USD 19.79 billion by 2033.
The clinical research segment is anticipated to witness the fastest CAGR of 38.98% over the forecast period.
The system segment garnered USD 1.82 billion in revenue in 2025.
Asia Pacific is anticipated to grow at a CAGR of 39% through the projection period.

How is accelerated drug discovery and development driving market growth?

Generative AI technologies enable pharmaceutical companies and researchers to rapidly identify promising drug candidates, design new molecules, and predict drug interactions with unprecedented speed and accuracy. By leveraging powerful machine learning models, these tools can analyze vast datasets, simulate biological processes, and generate hypotheses that traditionally would have required years of laboratory work.

Generative AI shortens development times, lowers research costs, and improves the likelihood of successful drug approvals. This expedited process is crucial for responding to emerging diseases and unmet medical needs, making it a transformational force in modern healthcare.

In March 2024, NVIDIA introduced a full suite of generative AI microservices for healthcare to power drug discovery, medical technology, and digital health. Advanced imaging, biological modeling, and natural language processing (NLP) capabilities enable the microservices to accelerate research, enhance diagnostics, and support the deployment of AI-powered clinical workflows into cloud systems, allowing healthcare organizations to leverage the potential of AI.

How does the risk of bias and inaccuracy hinder the growth of generative AI in healthcare market?

Risk of bias and inaccuracy are a critical challenge impeding the adoption of generative AI in healthcare. AI models can inadvertently perpetuate existing biases or produce inaccurate results if they are trained on unrepresentative, incomplete, or low-quality data. Such errors can negatively impact patient care, leading to misdiagnoses, unequal treatment, and diminished trust in AI systems.

Addressing this challenge requires rigorous validation and continuous monitoring of AI algorithms, as well as the use of diverse, high-quality training data. Additionally, fostering transparency in model development and implementing robust governance frameworks can help ensure that generative AI solutions are fair, accurate, and reliable in healthcare applications.

How is the expansion of multimodal diagnostics positively influencing the generative AI in healthcare market?

The rising trend of integrating different data types, such as medical images, laboratory tests, electronic health records, and genetic information, using advanced generative AI models is reshaping the market. These models can combine and analyze different data types simultaneously, allowing for more accurate and comprehensive diagnoses and the development of personalized treatment plans.

The increasing adoption of multimodal diagnostics is enabling physicians to diagnose complex conditions, facilitate early intervention, and enhance clinical workflows. This trend is likely to significantly impact patient outcomes and the overall quality of healthcare services, as a growing number of healthcare providers adopt these solutions.

In June 2024, Modella AI launched multimodal and generative AI models to improve pathology diagnostics. The technology combines pathology images with clinical information to increase accuracy and efficiency in disease detection, diagnosis, and reporting in medical imaging and laboratory processes.

Generative AI in Healthcare Market Report Snapshot

Segmentation	Details
By Component	Solution and Services
By Function	Virtual Nursing Assistants, Robot-Assisted AI Surgery, Administrative Process Optimization, Medical Imaging Analysis, and Others
By End Use	Clinical Research, Medical Centers, Diagnostic Centers, and Others
By Application	Clinical and System
By Region	North America: U.S., Canada, Mexico
	Europe: France, UK, Spain, Germany, Italy, Russia, Rest of Europe
	Asia-Pacific: China, Japan, India, Australia, ASEAN, South Korea, Rest of Asia-Pacific
	Middle East & Africa: Turkey, U.A.E., Saudi Arabia, South Africa, Rest of Middle East & Africa
	South America: Brazil, Argentina, Rest of South America

Market Segmentation

By Component (Solution and Services): The solution segment earned USD 1.84 billion in 2025, with the increasing need for sophisticated AI-powered platforms that assist in clinical documentation, diagnostics, and administrative tasks driving the revenue. The healthcare sector is experiencing rapid growth as providers continue to invest in generative AI solutions to gain efficiency, lower expenses, and offer personalized patient care.
By Function (Virtual Nursing Assistants, Robot-Assisted AI Surgery, Administrative Process Optimization, Medical Imaging Analysis, and Others): The administrative process optimization segment held a share of 56.95% in 2025, as generative AI solutions are increasingly used in administrative workflows to streamline clinical documentation, billing, scheduling, and claims processing. These solutions offer a highly appealing ROI for healthcare organizations looking to reduce administrative burdens, enhance workflow efficiency, and allocate more resources to patient care.
By End Use (Clinical Research, Medical Centers, Diagnostic Centers, and Others): The medical centers segment is projected to reach USD 17.63 billion by 2033, mainly driven by the integration of generative AI solutions for better patient management, efficient clinical processes, and better diagnostics. This growth is further boosted by the rising number of hospitals and health systems seeking to improve patient care and streamline processes.
By Application (Clinical and System): The clinical segment is anticipated to witness a CAGR of 38.52% over the forecast period, owing to the increasing application of generative AI in diagnostics and treatment planning, personalized medicine, and drug discovery. Healthcare providers are using these AI applications in clinical decision-making, thereby improving patient outcomes and accelerating research, which is supporting segmental growth.

What is the market scenario in North America and Asia Pacific?

Based on region, the global generative AI in healthcare market has been classified into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

North America generative AI in healthcare market share stood at 40.48% in 2025, with a valuation of USD 1.09 billion. This dominance is reinforced by the surging adoption of advanced healthcare technologies and the investments made by the governments and the private sector. Key factors contributing significantly to domestic market growth include the presence of major AI players, strong regulatory support for digital health innovations, and the increasing demand for improved patient care.

Furthermore, the region’s extensive use of electronic health records and a large pool of skilled professionals facilitate the seamless integration of generative AI technologies into clinical and administrative workflows. Strategic collaborations among technology companies, healthcare providers, and research institutions are also vital in driving innovation and scaling AI solutions in North America.

In February 2025, U.S.-based Validic announced the launch of a remote patient monitoring assistant that uses generative AI to analyze and summarize patient data trends within EHR workflows. The assistant is engineered to give clinicians actionable guidance, decrease information overload, and make care management simpler. The tool is designed to improve clinical efficiency and patient outcomes while remaining HIPAA-compliant.

The Asia Pacific generative AI in healthcare market is set to grow at a CAGR of 39% over the forecast period, largely fueled by digital transformation across healthcare systems and government support for AI-driven innovation. Growing investments in health technology, greater focus on patient-centric care, and rising adoption of electronic health records are driving the demand for generative AI applications.

The region’s large, diverse population generates vast amounts of healthcare data, enabling the development of highly effective AI models. Additionally, advancements in cloud computing and telemedicine, coupled with increased collaboration between technology providers and healthcare organizations, are fostering a dynamic environment for the expansion of generative AI solutions throughout the Asia Pacific healthcare sector.

In February 2026, JCHO Osaka Hospital, Fujitsu Japan, and Fortience Consulting initiated a project focused on the secure integration of generative AI throughout all aspects of medical operations. The initiative focuses on AI-powered discharge summaries and nursing handovers, aims to enhance efficiency and support work style reform, and will establish guidelines and governance for hospital-wide AI adoption.

Regulatory Frameworks

In the U.S., the Health Insurance Portability and Accountability Act (HIPAA) regulates the privacy and security of protected health information. It ensures that generative AI solutions handling patient data comply with strict standards for confidentiality and data protection within the healthcare sector.
In the European Union, the Medical Device Regulation (MDR) regulates AI-based medical devices. It requires comprehensive clinical evaluations, transparency, and post-market surveillance, ensuring that generative AI tools in healthcare are safe and effective.

Competitive Landscape

Major players operating in the generative AI in healthcare market are investing heavily in research and development to enhance AI capabilities and expand their product portfolios. Strategic collaborations between AI firms, pharmaceutical companies, and healthcare providers are common, accelerating the integration of generative AI solutions across clinical workflows.

Startups are driving innovation in areas such as drug discovery, medical imaging, and patient data synthesis, while established firms offer scalable platforms and regulatory expertise. Intense competition is fostering rapid technological advancement, improved solution quality, and the increasing adoption of generative AI throughout the global healthcare sector.

In November 2023, Wipro partnered with NVIDIA to accelerate generative AI adoption in healthcare and insurance. Leveraging NVIDIA AI Enterprise software, the partnership aims to improve member experience, streamline enrollment, and enhance claims processing by integrating large language models and AI-driven solutions across Wipro’s healthcare offerings.

Key Companies In The Generative AI in Healthcare Market

Microsoft
Google LLC
NVIDIA Corporation
Amazon Web Services, Inc.
IBM
Oracle
Abridge AI, Inc.
Insilico Medicine
Johnson & Johnson
SAXON INFOSYSTEMS
Tempus AI, Inc.
OpenAI
Hippocratic AI
John Snow Labs, Inc.
Aidoc

Recent Developments

In April 2024, the World Health Organization (WHO) introduced S.A.R.A.H., a digital health promoter powered by generative AI. S.A.R.A.H. provides real-time, empathetic health information in eight languages, helping users with topics ranging from healthy habits to chronic diseases, while seeking to improve access to reliable, up-to-date health advice globally.
In October 2025, IKS Health launched a generative AI platform on Google Cloud that will utilize a multi-agent system to automate administrative healthcare processes, including chart prep and prior authorizations. The aim is to combine AI and human review to enhance safety and accuracy, reduce clinician workload, and boost efficiency.
In June 2024, Cognizant launched its first set of healthcare large language model solutions using Google Cloud’s generative AI technology. Their solutions are designed to minimize manual mistakes, enhance efficiency, and improve satisfaction for both healthcare organizations and their members, with functions like contracting, plan selection, marketing, and appeals.
In July 2024, GE HealthCare and AWS announced a strategic collaboration to develop purpose-built foundation models and generative AI healthcare applications. The partnership aims to accelerate clinical and operational workflows, enhance diagnostics, and personalize care to enable secure, scalable, and efficient healthcare innovation, supported by AWS’s advanced AI cloud technologies.
In May 2025, Rad AI announced USD 8 million in strategic investment from health systems Advocate Health, Memorial Hermann, Corewell Health, and Atlantic Health System. The funding will accelerate the adoption of generative AI in hospitals to improve radiology workflows, quality of care, reporting, and patient follow-up.

Generative AI in Healthcare Market